Tata India Pharma & Healthcare RegIDCW-R
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation15.4%
Sharpe Ratio0.21
Beta1.00
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices7.99%
Abbott India LtdServices5.94%
HealthCare Global Enterprises LtdServices5.92%
Divi's Laboratories LtdServices5.68%
Dr Reddy's Laboratories LtdServices4.65%
Apollo Hospitals Enterprise LtdServices4.36%
Rainbow Childrens Medicare LtdServices4.30%
Cipla LtdServices4.22%
Torrent Pharmaceuticals LtdServices3.76%
Max Healthcare Institute Ltd Ordinary SharesServices3.71%
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.32%
Regulatory & Tax Information
INF277K018A5
ISINDailyDealing Frequency
BSE Healthcare PR INRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)